Document is current
Any future updates will be listed below
-
Authors
Saito, Tetsuichi
Hitchens, T. Kevin
Foley, Lesley M.
Singh, Nishant
Mizoguchi, Shinsuke
Kurobe, Masahiro
Gotoh, Daisuke
Ogawa, Teruyuki
Minagawa, Tomonori
Ishizuka, Osamu
Chermansky, Christopher
Kaufman, Jonathan
Yoshimura, Naoki
Tyagi, Pradeep
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (108397, 108397, 108397, 108397, 108397, 108397)
- License Information
-
More Information
Article History
Received: 18 February 2021
Accepted: 26 August 2021
First Online: 30 September 2021
Competing interests
: The authors declare no competing interests, except Jonathan Kaufmann, who is the CEO of Lipella Pharmaceuticals and an inventor of the contrast mixture used in the described study.
